Log in

CVE:RVVRevive Therapeutics Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume32,500 shs
Average Volume93,085 shs
Market CapitalizationC$3.62 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Revive Therapeutics Ltd. develops and commercializes cannabinoid-based products in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-004, a bucillamine for the treatment of cystinurial. The company has a research and development supply and collaboration agreement with WeedMD Inc. Revive Therapeutics Ltd. was incorporated in 2012 and is headquartered in Vaughan, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-905-6055535

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book ValueC$0.02 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$3.62 million
Next Earnings Date9/4/2020 (Estimated)
OptionableNot Optionable

Receive RVV News and Ratings via Email

Sign-up to receive the latest news and ratings for RVV and its competitors with MarketBeat's FREE daily newsletter.

Revive Therapeutics (CVE:RVV) Frequently Asked Questions

When is Revive Therapeutics' next earnings date?

Revive Therapeutics is scheduled to release its next quarterly earnings announcement on Friday, September 4th 2020. View our earnings forecast for Revive Therapeutics.

How were Revive Therapeutics' earnings last quarter?

Revive Therapeutics Ltd (CVE:RVV) released its earnings results on Friday, May, 29th. The company reported ($0.02) EPS for the quarter. View Revive Therapeutics' earnings history.

Has Revive Therapeutics been receiving favorable news coverage?

News articles about RVV stock have been trending negative recently, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Revive Therapeutics earned a coverage optimism score of -2.4 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about Revive Therapeutics.

Who are some of Revive Therapeutics' key competitors?

What other stocks do shareholders of Revive Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Revive Therapeutics investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aurora Cannabis (ACB), Aphria (APHA), BioCryst Pharmaceuticals (BCRX), Bristol-Myers Squibb (BMY), CytoDyn (CYDY), Enterprise Products Partners (EPD), EPR Properties (EPR) and GW Pharmaceuticals PLC- (GWPH).

Who are Revive Therapeutics' key executives?

Revive Therapeutics' management team includes the following people:
  • Mr. Craig Leon, Chairman & CEO (Age 51)
  • Mr. Fabio Chianelli, Pres & Director (Age 41)
  • Mr. Carmelo Marrelli C.A., C.P.A., CPA, B.Comm., CA, CGA, ACIS, Chief Financial Officer (Age 48)

What is Revive Therapeutics' stock symbol?

Revive Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RVV."

How do I buy shares of Revive Therapeutics?

Shares of RVV and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

How big of a company is Revive Therapeutics?

Revive Therapeutics has a market capitalization of C$0.00.

What is Revive Therapeutics' official website?

The official website for Revive Therapeutics is www.revivethera.com.

How can I contact Revive Therapeutics?

Revive Therapeutics' mailing address is 5 Director Crt Suite 105, WOODBRIDGE, ON L4L 4S5, Canada. The company can be reached via phone at +1-905-6055535.

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.